Federated clinical data refers to clinical data that is distributed across multiple organizations or entities, such as hospitals, clinics, research institutions, or public health agencies. This data may include patient demographic information, medical history, clinical diagnoses, laboratory results, and treatment outcomes, among other types of data.
Federated clinical data allows for the integration of data from multiple sources, which can provide a more comprehensive view of patient health and disease patterns. It also enables healthcare organizations and researchers to collaborate and share data in a secure and efficient manner.
In a federated clinical data model, each organization retains control over its own data, while sharing selected data with other entities for specific purposes, such as research studies or public health surveillance. This approach helps to ensure patient privacy and data security, while still allowing for the sharing of valuable information to advance healthcare and medical research.
The use of federated clinical data is becoming increasingly common as healthcare organizations seek to harness the power of big data and machine learning to improve patient outcomes, develop new treatments, and reduce healthcare costs.
Share this story...
Real World Evidence (RWE) 101 – Patient Retention
RWE 101 - Patient Retention Long-term Real-World Evidence (RWE) studies face significant challenges when it comes to patient retention, for several reasons:[1] Time Commitment: Participants in RWE studies are [...]
Real World Evidence (RWE) 101 – Patient Recruitment
RWE 101 - Patient Recruitment Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic [...]
Real World Evidence (RWE) 101 – HARPER
RWE 101 - HARPER Regulatory agencies, health technology assessors, and payers are increasingly interested in studies that make use of real-world data to inform regulatory and other policy or [...]
Real World Evidence (RWE) 101 – STaRT-RWE
RWE 101 - STaRT-RWE START-RWE (Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies) was developed to address the need for improved transparency and [...]
Real World Evidence (RWE) 101 – Protocol Design and ISPE GPP
RWE 101 - Protocol Design and ISPE GPP The International Society for Pharmacoepidemiology (ISPE) Guidelines for Good Pharmacoepidemiology Practices (GPP) are a set of best practices for the conduct [...]
Real World Evidence (RWE) 101 – Protocol Design and Scientific Best Practices
RWE 101 - Protocol Design and Scientific Best Practices Designing a robust Real-World Evidence (RWE) study is crucial for generating reliable and valid insights that are acceptable to regulators. [...]







